THE SYSTEM IS GETTING MORE EXPENSIVE… AND WE’RE GETTING SICKER

Healthcare costs are rising faster than people can realistically keep up with.

In the United States, total healthcare spending has surpassed $4.5 trillion per year, with average costs now exceeding $13,000 per person annually. Employer-sponsored insurance premiums have increased more than 50 percent over the past decade, and deductibles and out-of-pocket costs continue to climb. For most families, this means paying significantly more just to access care, before treatment even begins.

At the same time, the population is becoming less healthy, not more.

Only about 6.8 percent of U.S. adults are considered metabolically healthy. That means over 93 percent are dealing with some level of metabolic dysfunction, including obesity, insulin resistance, high blood pressure, or abnormal cholesterol levels. Rates of type 2 diabetes, cardiovascular disease, and fatty liver disease have all risen over the past two decades. These are largely preventable conditions driven by lifestyle and environmental factors, not random events.

Pharmaceutical spending and profits have increased alongside disease rates.

The United States represents a massive share of global pharmaceutical revenue, with drug prices often two to three times higher than in other developed countries. This is largely due to a lack of direct price regulation, extended patent protections, and a system that allows manufacturers to set pricing with limited restriction. Medications play a critical and often life-saving role, but the financial structure of the system is heavily weighted toward treating disease rather than preventing it.

The United States is one of only two countries that allows direct-to-consumer drug advertising.

Only the U.S. and New Zealand permit pharmaceutical companies to market prescription drugs directly to the public. This has been shown to increase demand for specific medications and influence patient requests during medical visits. It shifts part of the healthcare decision-making process toward consumer-driven demand rather than strictly physician-guided recommendations.

There is strong scientific evidence linking the modern food environment to rising disease rates.

The issue is not that food is literally poison, but that a large portion of the modern diet is dominated by ultra-processed products that are strongly associated with negative health outcomes. Diets high in added sugars, refined carbohydrates, industrial oils, and heavily processed ingredients are consistently linked to obesity, metabolic disease, cardiovascular disease, and increased mortality risk. Certain additives and emulsifiers have also been shown in research to negatively impact gut health and promote inflammation when consumed in excess.

This creates a clear and measurable contradiction.

The United States has some of the most advanced healthcare systems, the highest concentration of medical professionals, and the greatest access to health information in the world. At the same time, it has the highest healthcare spending and some of the worst rates of preventable chronic disease among developed nations. That disconnect is not theoretical. It is well documented across multiple public health and economic datasets.

The issue is not a single cause. It is a system-level problem driven by incentives.

The current structure rewards treatment more than prevention. Food environments make high-calorie, low-nutrient options widely accessible and heavily marketed. Healthcare systems are designed to manage disease after it develops. Pharmaceutical companies generate more revenue in a population with higher disease prevalence. Preventive strategies such as nutrition education, strength training, sleep optimization, and stress management receive far less emphasis despite strong evidence supporting their impact.

Access to healthcare does not automatically create a healthy population.

A system can have world-class doctors, hospitals, and medications, but if the foundational lifestyle inputs are unstable across the population, disease rates will continue to rise. Nutrition quality, physical activity, sleep, stress, hydration, and substance use all directly influence long-term health outcomes. When those factors are consistently poor at scale, healthcare costs increase regardless of how advanced the medical system becomes.

Bottom line.

Healthcare costs are rising while overall health continues to decline, and that pattern is supported by extensive data. The underlying issue is not one single factor but a misalignment between prevention, environment, and treatment. Until more emphasis is placed on improving the foundational drivers of health, costs will continue to rise while outcomes continue to worsen.

REFERENCES

Centers for Medicare & Medicaid Services (CMS) National Health Expenditure Data

Kaiser Family Foundation Employer Health Benefits Survey

NHANES (National Health and Nutrition Examination Survey)

Journal of the American College of Cardiology: prevalence of metabolic health

Monteiro et al., BMJ – Ultra-processed food and health outcomes

Hall et al., Cell Metabolism – ultra-processed diets and calorie intake

American Heart Association – added sugars and cardiovascular risk

OECD Health Statistics – international healthcare spending comparisons

Ventola CL. P&T Journal – Direct-to-consumer pharmaceutical advertising

IQVIA Institute – Global Medicine Spending and Use Reports